FDMT icon

4D Molecular Therapeutics

100 hedge funds and large institutions have $745M invested in 4D Molecular Therapeutics in 2023 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 48 increasing their positions, 19 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
+6
Holders Change %
+6.38%
% of All Funds
1.58%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
22
Increased
48
Reduced
19
Closed
16
Calls
$1.3M
Puts
$1.89M
Net Calls
-$595K
Net Calls Change
+$153K
Name Holding Trade Value Shares
Change
Shares
Change %
OCA
101
Octagon Capital Advisors
New York
-$8.59M -499,996 Closed
Norges Bank
102
Norges Bank
Norway
-$5.05M -294,000 Closed
ACP
103
Acuta Capital Partners
California
-$1.8M -104,753 Closed
D.E. Shaw & Co
104
D.E. Shaw & Co
New York
-$1.4M -81,457 Closed
Vontobel Holding
105
Vontobel Holding
Switzerland
-$1.38M -80,529 Closed
SAM
106
Sectoral Asset Management
Quebec, Canada
-$1.38M -80,029 Closed
Marshall Wace
107
Marshall Wace
United Kingdom
-$584K -33,954 Closed
LCM
108
Laurion Capital Management
New York
-$368K -21,401 Closed
AG
109
Algert Global
California
-$282K -16,410 Closed
PWS
110
Peloton Wealth Strategists
Indiana
-$275K -16,000 Closed
Renaissance Technologies
111
Renaissance Technologies
New York
-$237K -13,800 Closed
PP
112
PDT Partners
New York
-$186K -10,795 Closed
SG Americas Securities
113
SG Americas Securities
New York
-$108K -6,275 Closed
DA
114
Denali Advisors
California
-$34.4K -2,000 Closed
TWA
115
TCI Wealth Advisors
Arizona
-$3.22K -187 Closed
CA
116
Crewe Advisors
Utah
-$2.44K -142 Closed